Chlorpheniramine maleate - Dr. Ferrer Biopharma
Alternative Names: Chlorpheniramine maleate 1% nasal spray; ClorNasal; ClorNovirLatest Information Update: 25 Sep 2023
At a glance
- Originator Dr. Ferrer BioPharma
- Class Anti-inflammatories; Antiallergics; Antivirals; Sedating antihistamines; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II/III COVID 2019 infections
Most Recent Events
- 11 Mar 2022 Dr. Ferrer Biopharma completes phase-II/III ACCROS-I trial in COVID-2019 infections (In adults) in Honduras (Intranasal) (NCT05449405)